The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells
- PMID: 33097091
- PMCID: PMC7585203
- DOI: 10.1186/s13072-020-00366-4
The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells
Abstract
The chromatin-binding E3 ubiquitin ligase ubiquitin-like with PHD and RING finger domains 1 (UHRF1) contributes to the maintenance of aberrant DNA methylation patterning in cancer cells through multivalent histone and DNA recognition. The tandem Tudor domain (TTD) of UHRF1 is well-characterized as a reader of lysine 9 di- and tri-methylation on histone H3 (H3K9me2/me3) and, more recently, lysine 126 di- and tri-methylation on DNA ligase 1 (LIG1K126me2/me3). However, the functional significance and selectivity of these interactions remain unclear. In this study, we used protein domain microarrays to search for additional readers of LIG1K126me2, the preferred methyl state bound by the UHRF1 TTD. We show that the UHRF1 TTD binds LIG1K126me2 with high affinity and selectivity compared to other known methyllysine readers. Notably, and unlike H3K9me2/me3, the UHRF1 plant homeodomain (PHD) and its N-terminal linker (L2) do not contribute to multivalent LIG1K126me2 recognition along with the TTD. To test the functional significance of this interaction, we designed a LIG1K126me2 cell-penetrating peptide (CPP). Consistent with LIG1 knockdown, uptake of the CPP had no significant effect on the propagation of DNA methylation patterning across the genomes of bulk populations from high-resolution analysis of several cancer cell lines. Further, we did not detect significant changes in DNA methylation patterning from bulk cell populations after chemical or genetic disruption of lysine methyltransferase activity associated with LIG1K126me2 and H3K9me2. Collectively, these studies identify UHRF1 as a selective reader of LIG1K126me2 in vitro and further implicate the histone and non-histone methyllysine reader activity of the UHRF1 TTD as a dispensable domain function for cancer cell DNA methylation maintenance.
Conflict of interest statement
B.D.S and M.T.B. are co-founders of Epicypher, Inc. The other authors declare that they have no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig5_HTML.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585203/bin/13072_2020_366_Fig6_HTML.gif)
Similar articles
-
Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation.Structure. 2019 Mar 5;27(3):485-496.e7. doi: 10.1016/j.str.2018.11.012. Epub 2019 Jan 10. Structure. 2019. PMID: 30639225
-
Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein.J Biol Chem. 2013 Jan 11;288(2):1329-39. doi: 10.1074/jbc.M112.415398. Epub 2012 Nov 16. J Biol Chem. 2013. PMID: 23161542 Free PMC article.
-
Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2.Proteins. 2022 Mar;90(3):835-847. doi: 10.1002/prot.26278. Epub 2021 Nov 19. Proteins. 2022. PMID: 34766381
-
Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.Biochem Pharmacol. 2013 Dec 15;86(12):1643-9. doi: 10.1016/j.bcp.2013.10.002. Epub 2013 Oct 14. Biochem Pharmacol. 2013. PMID: 24134914 Review.
-
Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.J Exp Clin Cancer Res. 2011 Apr 15;30(1):41. doi: 10.1186/1756-9966-30-41. J Exp Clin Cancer Res. 2011. PMID: 21496237 Free PMC article. Review.
Cited by
-
Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells.Nat Commun. 2024 Apr 5;15(1):2960. doi: 10.1038/s41467-024-47314-4. Nat Commun. 2024. PMID: 38580649 Free PMC article.
-
Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry.Biosci Rep. 2023 Oct 31;43(10):BSR20231093. doi: 10.1042/BSR20231093. Biosci Rep. 2023. PMID: 37782747 Free PMC article.
-
Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.Molecules. 2023 Aug 10;28(16):5997. doi: 10.3390/molecules28165997. Molecules. 2023. PMID: 37630248 Free PMC article. Review.
-
Refined read-out: The hUHRF1 Tandem-Tudor domain prefers binding to histone H3 tails containing K4me1 in the context of H3K9me2/3.Protein Sci. 2023 Sep;32(9):e4760. doi: 10.1002/pro.4760. Protein Sci. 2023. PMID: 37593997 Free PMC article.
-
Large-Scale Chromatin Rearrangements in Cancer.Cancers (Basel). 2022 May 12;14(10):2384. doi: 10.3390/cancers14102384. Cancers (Basel). 2022. PMID: 35625988 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous